Literature DB >> 21474820

Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.

Meena S Madhur1, Samuel A Funt, Li Li, Antony Vinh, Wei Chen, Heinrich E Lob, Yoichiro Iwakura, Yelena Blinder, Ayaz Rahman, Arshed A Quyyumi, David G Harrison.   

Abstract

OBJECTIVE: Interleukin 17A (IL17A) is involved in many inflammatory processes, but its role in atherosclerosis remains controversial. We examined the role of IL17A in mouse and human atherosclerosis. METHODS AND
RESULTS: Atherosclerosis was induced in apolipoprotein E (ApoE)(-/-) and IL17A/ApoE(-/-) mice using high-fat feeding, angiotensin II infusion, or partial carotid ligation. In ApoE(-/-) mice, 3 months of high-fat diet induced interferon-γ production by splenic lymphocytes, and this was abrogated in IL17A/ApoE(-/-) mice. IL17A/ApoE(-/-) mice had reduced aortic superoxide production, increased aortic nitric oxide levels, decreased aortic leukocyte and dendritic cell infiltration, and reduced weight gain after a high-fat diet compared with ApoE(-/-) mice. Despite these favorable effects, IL17A deficiency did not affect aortic plaque burden after a high-fat diet or angiotensin II infusion. In a partial carotid ligation model, IL17A deficiency did not affect percentage of stenosis but reduced outward remodeling. In this model, neutralization of the related isoform, IL17F, in IL17A/ApoE(-/-) mice did not alter atherosclerosis. Finally, there was no correlation between IL17A levels and carotid intima-media thickness in humans.
CONCLUSIONS: IL17 contributes to vascular and systemic inflammation in experimental atherosclerosis but does not alter plaque burden. The changes in plaque composition caused by IL17 might modulate plaque stability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474820      PMCID: PMC3117048          DOI: 10.1161/ATVBAHA.111.227629

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  35 in total

1.  Fatty streak formation in fat-fed mice expressing human copper-zinc superoxide dismutase.

Authors:  D L Tribble; E L Gong; C Leeuwenburgh; J W Heinecke; E L Carlson; J G Verstuyft; C J Epstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-09       Impact factor: 8.311

2.  Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study.

Authors:  M L Bots; A W Hoes; P J Koudstaal; A Hofman; D E Grobbee
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

3.  Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.

Authors:  Laurie E Harrington; Robin D Hatton; Paul R Mangan; Henrietta Turner; Theresa L Murphy; Kenneth M Murphy; Casey T Weaver
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

4.  Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation.

Authors:  Svetlana Sergejeva; Stefan Ivanov; Jan Lötvall; Anders Lindén
Journal:  Am J Respir Cell Mol Biol       Date:  2005-05-18       Impact factor: 6.914

5.  Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E.

Authors:  Hong Yang; L Jackson Roberts; Ming Jian Shi; Li Chun Zhou; Billy R Ballard; Arlan Richardson; Zhong Mao Guo
Journal:  Circ Res       Date:  2004-11-04       Impact factor: 17.367

6.  Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women.

Authors:  M Sumarac-Dumanovic; D Stevanovic; A Ljubic; J Jorga; M Simic; D Stamenkovic-Pejkovic; V Starcevic; V Trajkovic; D Micic
Journal:  Int J Obes (Lond)       Date:  2008-11-04       Impact factor: 5.095

7.  The Th17/Treg imbalance in patients with acute coronary syndrome.

Authors:  Xiang Cheng; Xian Yu; Ying-Jun Ding; Qing-Qing Fu; Jiang-Jiao Xie; Ting-Ting Tang; Rui Yao; Yong Chen; Yu-Hua Liao
Journal:  Clin Immunol       Date:  2008-02-21       Impact factor: 3.969

Review 8.  Th17 cells in human disease.

Authors:  Laura A Tesmer; Steven K Lundy; Sujata Sarkar; David A Fox
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

9.  N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?

Authors:  Z S Galis; K Asanuma; D Godin; X Meng
Journal:  Circulation       Date:  1998-06-23       Impact factor: 29.690

10.  Compensatory vascular remodeling during atherosclerotic lesion growth depends on matrix metalloproteinase-9 activity.

Authors:  Susan M Lessner; Deborah E Martinson; Zorina S Galis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-12       Impact factor: 8.311

View more
  95 in total

1.  The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment.

Authors:  Matthew J Butcher; Breanne N Gjurich; Tracy Phillips; Elena V Galkina
Journal:  Circ Res       Date:  2012-02-02       Impact factor: 17.367

Review 2.  Vascular Adaptation to Exercise in Humans: Role of Hemodynamic Stimuli.

Authors:  Daniel J Green; Maria T E Hopman; Jaume Padilla; M Harold Laughlin; Dick H J Thijssen
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 3.  Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy.

Authors:  Matthew A Dale; Melissa K Ruhlman; B Timothy Baxter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-04       Impact factor: 8.311

4.  Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice.

Authors:  Wuzhou Wan; Jean K Lim; Michail S Lionakis; Aymeric Rivollier; David H McDermott; Brian L Kelsall; Joshua M Farber; Philip M Murphy
Journal:  Circ Res       Date:  2011-06-16       Impact factor: 17.367

5.  IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.

Authors:  Christian Erbel; Mohammadreza Akhavanpoor; Deniz Okuyucu; Susanne Wangler; Alex Dietz; Li Zhao; Konstantinos Stellos; Kristina M Little; Felix Lasitschka; Andreas Doesch; Maani Hakimi; Thomas J Dengler; Thomas Giese; Erwin Blessing; Hugo A Katus; Christian A Gleissner
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

Review 6.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

7.  The transcription factor CREB enhances interleukin-17A production and inflammation in a mouse model of atherosclerosis.

Authors:  Sivareddy Kotla; Nikhlesh K Singh; Mark R Heckle; Gabor J Tigyi; Gadiparthi N Rao
Journal:  Sci Signal       Date:  2013-09-17       Impact factor: 8.192

Review 8.  Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension.

Authors:  Isola A M Brown; Lukas Diederich; Miranda E Good; Leon J DeLalio; Sara A Murphy; Miriam M Cortese-Krott; Jennifer L Hall; Thu H Le; Brant E Isakson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

9.  Sex-specific T-cell regulation of angiotensin II-dependent hypertension.

Authors:  Hong Ji; Wei Zheng; Xiangjun Li; Jun Liu; Xie Wu; Monan Angela Zhang; Jason G Umans; Meredith Hay; Robert C Speth; Shannon E Dunn; Kathryn Sandberg
Journal:  Hypertension       Date:  2014-06-16       Impact factor: 10.190

10.  CXCR6 regulates the recruitment of pro-inflammatory IL-17A-producing T cells into atherosclerotic aortas.

Authors:  Matthew J Butcher; Chih-I Wu; Tayab Waseem; Elena V Galkina
Journal:  Int Immunol       Date:  2015-11-27       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.